IkB kinase b (IKKb), a central coordinator of inflammatory responses through activation of nuclear factor-kB (NF-kB), has been implicated as a critical molecular link between inflammation and metabolic disorders; however, the role of adipocyte IKKb in obesity and related metabolic disorders remains elusive. Here we report an essential role of IKKb in the regulation of adipose remodeling and adipocyte survival in diet-induced obesity. Targeted deletion of IKKb in adipocytes does not affect body weight, food intake, and energy expenditure but results in an exaggerated diabetic phenotype when challenged with a high-fat diet (HFD). IKKb-deficient mice have multiple histopathologies in visceral adipose tissue, including increased adipocyte death, amplified macrophage infiltration, and defective adaptive adipose remodeling. Deficiency of IKKb also leads to increased adipose lipolysis, elevated plasma free fatty acid (FFA) levels, and impaired insulin signaling. Mechanistic studies demonstrated that IKKb is a key adipocyte survival factor and that IKKb protects murine and human adipocytes from HFD-or FFA-elicited cell death through NF-kB-dependent upregulation of antiapoptotic proteins and NF-kB-independent inactivation of proapoptotic BAD protein. Our findings establish IKKb as critical for adipocyte survival and adaptive adipose remodeling in obesity.
It is generally accepted that obesity is associated with a state of chronic low-grade inflammation that is a major contributor to insulin resistance and type 2 diabetes, yet the detailed molecular mechanisms remain elusive (1-3).
IkB kinase b (IKKb), a central coordinator of inflammatory responses through activation of nuclear factor-kB (NF-kB) (4-6), has been implicated as a key molecular link between obesity, inflammation, and metabolic disorders (7, 8) . It is known that overnutrition can activate IKKb in vitro and in vivo (3, 9, 10) and that diet-induced insulin resistance has been associated with the activation of IKKb/NF-kB in multiple tissues (9, (11) (12) (13) (14) (15) . Moreover, heterozygous deletion of IKKb or inhibiting IKKb with salicylates protected mice against insulin resistance triggered by high-fat (HF) diet (HFD) or obesity (11, 16) . Deletion of IKKb in the liver improved diet-induced insulin resistance, and deficiency of IKKb in myeloid cells rendered global insulin sensitivity upon HF feeding (12) . By contrast, constitutive activation of IKKb in the liver caused systemic insulin resistance (13) .
Compared with other tissues and cell types, the role of adipose IKKb signaling in obesity and metabolic disorders remains incompletely understood. Obesity is associated with elevated activity of IKKb and another key stress/ inflammatory kinase, c-Jun amino-terminal kinase (JNK), in adipose tissue (3, 9, 17) . The contribution of JNK signaling to obesity-associated insulin resistance has been well-established (3, 17) . Although the role of IKKb in inflammatory factor-mediated adipocyte insulin resistance has been confirmed by in vitro studies (9, 18) , in vivo studies using transgenic or knockout mice have generated inconsistent results. For example, overexpression of NF-kB subunit p65 or a constitutive active form of IKKb in adipose tissue increased systemic and tissue inflammation but also resulted in improved insulin sensitivity (19, 20) .
A very recent study showed that the adipocyte IKKb also plays an important role in inflammation resolution by inducing interleukin 13 (IL-13) expression in adipose tissue (21) . We previously demonstrated that IKKb functions in adipocyte precursor cells to regulate adipogenesis and adipose tissue development (6) . Deficiency of IKKb in adipocyte precursor cells inhibited adipocyte differentiation and protected mice from diet-induced obesity and metabolic disorders (6) . These findings suggest that the functions of IKKb signaling in adipose tissue are complex and that further studies are needed to define the role of adipocyte IKKb in obesity and insulin resistance.
The adipocyte is subject to constant turnover once formed, and obesity is associated with a higher adipocyte turnover due to an elevated rate of adipocyte death (22, 23) . In addition to mediating inflammatory responses, IKKb is also a key cell survival factor (4,5) but the functions of IKKb in adipocyte survival has not been thoroughly investigated under the condition of obesity. We demonstrate here that IKKb plays an essential role in the regulation of adipocyte survival in diet-induced obesity and is required for adaptive adipose remodeling in response to nutrient changes.
RESEARCH DESIGN AND METHODS

Animals
Adipocyte-specific IKKb-knockout (IKKb DAd ) mice were generated by crossing IKKb F/F mice (6,24) with AdipoqCre transgenic mice (25) . IKKb F/F mice were also mated with aP2-Cre mice to generate IKKb DaP2 mice. IKKbdeficient mice and IKKb F/F control littermates (4 weeks old) were fed a normal chow diet (ND) or a Western-type HFD (42% kcal from fat; Harlan Teklad) for 12 weeks until they were killed at 16 weeks of age (6) . For the HFD-to-ND (HFD/ND) conversion diet experiment, mice were fed the HFD for 24 weeks then switched to the ND for 6 weeks. All animals were housed in an animal facility under a protocol approved by the University of Kentucky Institutional Animal Care and Use Committee.
Metabolic and Histological Analyses
Body weight was measured weekly, and body composition was measured by MRI (Echo MRI). Food intake, total activity, oxygen consumption, and carbon dioxide production were measured with a LabMaster system (6) . Intraperitoneal glucose tolerance test and insulin tolerance test were performed as described previously (6) . Ex vivo lipolysis was performed by using a Lipolysis Assay Kit (ZenBio) following the manufacturer's protocol. Immunohistochemical staining of adipose tissue sections was performed following standard protocols (6) . TUNEL staining for adipose tissue sections was performed using the In Situ Cell Death Detection Kit (Roche Applied Science).
MRI Analysis and Data Segmentation
HFD-fed IKKb
DAd and IKKb F/F littermates were imaged on a 7T CliniScan MRI (Bruker, Ettlingen, Germany). The fat and water images were generated from the in and out of phase images using Siemens Syngo software. FSL software was used for image analysis, and fat volume was calculated following standard protocols (26, 27) .
Adipose Stromal Vascular Cell Isolation and Analyses
Adipose stromal vascular (SV) cells and adipocytes were isolated as previously described (6) . Flow cytometry analysis was performed using freshly isolated SV cells labeled with Alexa Fluor 488-F4/80 (Serotec) and PE-CD11b (BD Biosciences) antibodies. For the Cre-mediated IKKb deletion assay, fully differentiated SV cells from IKKb F/F mice were infected with lentivirus expressing Cre or LacZ as the control. Cells were treated with a 0.5 mmol/L free fatty acid (FFA) mixture containing myristic, lauric, arachidonic, oleic, and linoleic acids (Sigma-Aldrich) or vehicle in the presence of 1% FFA-free BSA (9,10).
3T3-L1 Cell Differentiation and Short Interfering RNA Knockdown
3T3-L1 cells were first differentiated into mature adipocytes as previously described (6) . Differentiated 3T3-L1 cells were transfected with control short interfering (si)RNA or siRNA targeting the mouse IKKb or BAD gene sequences by electroporation using the Amaxa Cell Line Nucleofector Kit V (Lonza) (6) . Cells were treated with 0.5 mmol/L FFA mixture or vehicle for Western blot analysis.
Quantitative PCR and Western Blot Analyses
Quantitative PCR and Western blot analyses were performed as described before (6, 28, 29) . The primer sets used in this study are listed in Supplementary Table 1 . Anti-phosphorylated (phospho)-BAD (Ser26) antibody was purchased from Abiocode, anti-actin antibody was purchased Sigma-Aldrich, and all of the other antibodies were purchased from Cell Signaling.
Human Subjects and Adult-Derived Human Adipose Stem Cell Isolation
Human adipocytes were derived from the differentiation of adult-derived human adipose stem cells (ADHASCs) (30, 31) . The adipose tissue was from a collagenase digestion of the lipoaspirate of young and healthy subjects undergoing liposuction of subcutaneous fat. Differentiation medium was used to induce differentiation, as previously described (30, 31) .
Statistical Analysis
Data are presented as the mean 6 SEM. Individual pairwise comparisons were analyzed by two-sample, twotailed Student t test in which P , 0.05 was regarded as significant. (25, 32) . As expected, IKKb mRNA levels were significantly reduced in white adipose tissue (WAT), including subcutaneous WAT (subWAT) and epididymal WAT (epiWAT), and in brown adipose tissue (BAT), but not in other major tissues or cell types such as liver and macrophages of IKKb DAd mice (Fig. 1A) . Western blot analysis also confirmed the deletion of IKKb in WAT but not in liver or macrophages (Fig. 1B) (Fig. 1C) . 
RESULTS
IKKb
DAd mice were also phenotypically normal in food intake, oxygen consumption, and carbon dioxide production compared with IKKb F/F mice ( Fig. 1D- 
G). Unexpectedly, HFD-fed IKKb
DAd mice developed an exaggerated diabetic phenotype. Upon glucose and insulin tolerance testing, IKKb DAd mice had worse glucose tolerance ( Fig. 1H ) and showed a decreased hypoglycemic response to the injected insulin (Fig. 1I) . Further, deficiency of adipocyte IKKb also elevated fasting serum insulin concentrations (Fig. 1J) , suggesting worse insulin sensitivity.
Loss of Adipocyte IKKb Causes Partial Lipodystrophy and Defects in Adaptive Adipose Remodeling in Response to Dietary Changes
Intriguingly, we found that visceral (vis) adipose pads including epididymal (epi) and retroperitoneal fat pads of IKKb DAd mice failed to expand properly in response to HF feeding ( Fig. 2A and B) . MRI analyses confirmed that IKKb DAd mice had a significantly decreased volume of visWAT but a similar subWAT volume compared with IKKb F/F mice after HF feeding (Fig. 2C and D) . Histological analyses showed that visWAT of HFD-fed IKKb DAd mice exhibited a form of lipodystrophy with striking structure abnormalities and marked heterogeneity in adipocyte sizes (Fig. 3A) . Massively increased collagen deposition in epiWAT of HFD-fed IKKb DAd mice was confirmed by Masson's trichrome stain (Fig. 3B) . Quantification of adipocyte sizes demonstrated the aberrant adipocyte size distribution in IKKb-deficient mice (Fig. 3C ). These histopathological phenotypes suggest that visWAT of IKKb DAd mice failed to execute the appropriate adipose remodeling program in response to HFD stress. Because adipose tissue needs to expand and contract properly in response to nutrient status, we then tested whether adipocyte IKKb plays a role in adipose tissue contraction capacity on withdrawal from the HFD. HFDfed IKKb
DAd and control littermates were switched to the ND for 6 weeks. The control and IKKb DAd mice both had similar decreased body weight in response to the HFD/ND change (Fig. 4A) . Although subWAT was similar in IKKb DAd and IKKb F/F mice, IKKb DAd mice had much smaller and discolored epiWAT ( Fig. 4B and C) . Histological examination revealed a normal subWAT phenotype but severe degeneration of architecture and integrity in epiWAT of IKKb DAd , indicative of defective adipose remodeling (Fig. 4D) . Immunofluorescence staining confirmed the loss of perilipin, an adipocyte marker, for many cells in epiWAT of IKKb DAd mice, suggesting increased adipocyte death (Fig. 4E) . Further, unusual granuloma-like structures were also abundant in epiWAT of HFD/ND-fed IKKb DAd mice ( Fig. 4C and D) , which were also observed in other mouse models of lipodystrophy (33) . Taken together, the results from HFD-fed and HFD/ND-fed mice demonstrate the requirement of IKKb in adaptive adipose tissue remodeling in response to dietary changes.
IKKb Protects Adipocytes From HFD-Induced Cell Death
Obesity is associated with increased adipocyte death (23, 34, 35) , and IKKb is a well-established cell survival factor (4, 5) . Indeed, further analysis of WAT with TUNEL staining showed increased number of apoptotic (TUNEL-positive) cells in epiWAT of HFD-fed IKKb DAd mice (Fig. 5A) . Immunostaining of perilipin demonstrated that IKKb DAd mice had many adipocytes that were devoid of perilipin labeling (Fig. 5B) . Western blot analysis showed that HF feeding activated IKKb/NF-kB signaling in epiWAT of IKKb F/F mice, as indicated by increased IKKb expression and phosphorylation of the IKKb substrates IkBa and p65 (Fig. 5C ). In addition, JNK was also activated by HF feeding in epiWAT of IKKb F/F mice and further enhanced in that of IKKb DAd mice (Fig. 5C ). Although JNK signaling induces cell death, activation of NF-kB has been well known to inhibit JNK activation through upregulation of its target genes (36, 37) . Several NF-kB-regulated antiapoptotic proteins, including X-linked inhibitor of apoptosis (XIAP) and Bcl2, were increased in epiWAT of HFD-fed control mice but were repressed in that of IKKb DAd mice (Fig. 5C ). In addition to the NF-kB-dependent mechanism, IKKb can also inhibit cell death in an NF-kB-independent manner by phosphorylating BAD, a BH3-only proapoptotic protein, to prime it for inactivation (38) . Using a specific antibody against phospho-BAD (serine-26) (38), we also found that deficiency of IKKb abolished HFD-elicited BAD phosphorylation without affecting total BAD protein levels (Fig. 5C) . Consistently, the levels of activated caspase-3 and cleaved poly(ADP-ribose) polymerase (PARP) proteins, indicators of cell apoptosis, were markedly increased in epiWAT of HFD-fed IKKb DAd mice (Fig. 5C) . Collectively, these results suggest that IKKb protects visceral adipocytes from HFD-induced cell death.
IKKb-Deficient Mice Have Increased Adipose Tissue Macrophage Infiltration and Elevated Lipolysis in Visceral Adipose Depots
Adipocyte death has been implied as one of initial events that leads to adipose tissue macrophage (ATM) infiltration (33) (34) (35) 39) . Indeed, ATM infiltration was substantially increased in epiWAT of IKKb DAd upon the HFD challenge (Fig. 6A) . Flow cytometric analyses confirmed that the F4/80 + CD11b
+ macrophage population significantly increased in IKKb DAd mice (Fig. 6B) . Consistently, the mRNA levels of macrophage markers and several key proinflammatory cytokines, including tumor necrosis factor-a (TNF-a), MCP-1, and IL-2, generally considered M1 macrophage markers, were significantly elevated in epiWAT of IKKb DAd mice (Fig. 6C ). In addition, we also noticed the increased expression of IL-10 and Arg 1, markers for antiinflammatory M2 macrophages, coincident with the increased adipocyte death. Interestingly, the expression levels of IL-13, another anti-inflammatory cytokine, were also significantly increased in epiWAT of IKKb DAd mice (Fig.  6C) . By contrast, deficiency of IKKb did not affect the adipocyte apoptotic signaling in subWAT ( Supplementary  Fig. 2) or the ATM accumulation in subWAT (Fig. 6A) . The expression levels of macrophage markers and most proinflammatory cytokines in subWAT were also comparable to that of IKKb F/F mice (Fig. 6C ). Increased ATM number has been associated with elevated adipose lipolysis (40) , and some proinflammatory cytokines, such as TNF-a, can also stimulate basal lipolysis in adipocytes (23, 41) . We found that epiWAT of IKKb DAd mice also had significantly increased basal lipolysis but similar stimulated lipolysis compared with that of IKKb F/F mice (Fig. 6D) . Consistently, IKKb DAd mice had elevated plasma FFA levels as well as increased hepatic cholesterol and triglyceride concentrations (Fig. 6E-G) . It is well established that increased plasma FFA levels and ectopic lipid accumulation in the liver impair insulin signaling and are highly responsible for insulin resistance. Next, HFD-fed mice IKKb F/F and IKKb DAd mice were injected with insulin before being killed, and phosphorylation of Akt was analyzed in the liver and WAT. IKKb DAd mice had decreased phosphorylation of Akt in response to insulin in WAT and in the liver (Fig. 6H) , indicative of impaired insulin signaling in these mice. 
aP2-Cre-Mediated IKKb Deletion Also Results in Defects in Adipose Remodeling and Accentuated Inflammatory Responses After HF Feeding
To further confirm the role of IKKb in adipose tissue remodeling and adipocyte survival, we also used aP2-Cre transgenic mice to generate IKKb DaP2 mice, another adipose IKKb-deficient mouse model. As expected, the aP2-Cre line also led to effective deletion of IKKb in WAT of IKKb DaP2 mice (Fig. 7A) . Consistent with previous reports demonstrating that the aP2 promoter is expressed by other cell types, including macrophages (42, 43) , IKKb expression levels were also decreased in macrophages of IKKb DaP2 mice (Fig. 7A ). Similar to IKKb DAd mice, IKKb DaP2 mice displayed no significant phenotype under standard laboratory conditions and had similar body weight gain as littermate controls when challenged with the HFD (Fig. 7B) . HFD-fed IKKb DaP2 mice also had decreased size and weight of epiWAT but comparable BAT and subWAT compared with control mice (Fig. 7C and D) . Although IKKb DaP2 mice had IKKb deficiency in adipocytes and macrophages, the epiWAT of IKKb DaP2 mice exhibited the same histopathologies as that of IKKb DAd mice, including aberrant adipose tissue expansion, increased heterogeneity in adipocyte sizes, and increased ATM accumulation (Fig. 7E  and F) . Therefore, these results confirmed that deficiency of IKKb in adipocytes caused the defects in adipose remodeling and increased inflammatory responses after HFD feeding.
IKKb-BAD Axis Is Required for Adipocyte Survival in Response to FFAs In Vitro
We next used cultured 3T3-L1 adipocytes as a model system to further investigate the role of IKKb in adipocyte survival in response to overnutrition. Differentiated 3T3-L1 cells were introduced with control siRNA or siRNA against IKKb (Fig. 8A ) and then treated with a mixture of FFAs that activate IKKb and induce adipocyte inflammation (9, 10, 18) . FFA treatment activated IKKb and increased phospho-IkBa and phospho-p65 levels in control but not in siIKKb 3T3-L1 adipocytes (Fig. 8A) . The levels of NF-kB-regulated antiapoptotic proteins, Bcl2 and XIAP, were suppressed by IKKb knockdown, and FFA-elicited JNK activation was further enhanced in IKKb-deficient cells (Fig. 8A) . FFAs also induced IKKbmediated BAD phosphorylation in control but not in siIKKb adipocytes (Fig. 8A) . As a consequence, reduction of IKKb expression increased FFA-triggered cell death as indicated by elevated levels of activated caspase-3 and cleaved PARP proteins (Fig. 8A ) and increased TUNEL staining (Supplementary Fig. 3) .
To determine the importance of the NF-kB-independent mechanism in mediating adipocyte survival, we also used siRNA to knockdown BAD in control or siIKKb 3T3-L1 cells (Fig. 8B) . Knockdown of BAD did not affect control adipocytes that had intact IKKb/NF-kB signaling but protected siIKKb 3T3-L1 cells from FFA-induced cell death (Fig. 8B) . In addition to genetic approaches, we also used a highly selective IKKb inhibitor, BMS-345541 (6, 44) , and found that BMS-345541 treatment efficiently blocked IKKb-mediated IkBa phosphorylation elicited by FFAs (Fig. 8C) . BMS-345541-treated cells were more susceptible from FFA-induced cell death, as indicated by increased cleaved PARP and caspase-3 levels (Fig. 8C) . However, knockdown of BAD protected BMS-345541-treated cells against FFA-induced cell death (Fig. 8C) . Collectively, these results suggest that the newly identified IKKb-BAD axis plays a critical role in protecting adipocytes from FFA-induced cell death. + cells are as indicated in the flow profiles (n = 3-5). P < 0.05. C: Expression levels of macrophage markers and inflammatory genes in epiWAT and subWAT of HFD-fed mice were analyzed by quantitative PCR (n = 6). *P < 0.05; **P < 0.01; ***P < 0.001. D: Glycerol release in epiWAT from HFD-fed IKKb F/F and IKKb DAd mice under basal conditions or stimulated with 1 mmol/L isoproterenol (n = 9-12). *P < 0.05. Plasma FFA concentration (E) and hepatic cholesterol (F) and triglyceride (G) levels in HFD-fed IKKb F/F and IKKb DAd mice (n = 9-13). *P < 0.05. H: Western blot analysis of phospho(p)-Akt (ser473) and total Akt levels in liver and epiWAT of HFD-fed IKKb F/F and IKKb DAd mice injected with saline or 0.35 units/kg body weight insulin.
IKKb Protects Primary Murine and Human Adipocytes From FFA-Induced Cell Death
Lastly, we investigated the effect of IKKb-deficiency on primary murine and human adipocyte survival. Adipose SV cells were isolated from IKKb F/F mice, differentiated into mature adipocytes, and then infected with lentivirus expressing Cre to acutely delete IKKb (Fig. 8D) . Deficiency of IKKb enhanced FFA-elicited JNK activation (Fig. 8D) but abolished FFA-induced BAD phosphorylation (Fig. 8E) . Accordingly, FFA treatment increased activated caspase-3 and cleaved PARP levels in IKKb-deficient cells but not in control cells (Fig. 8E) .
ADHASCs were isolated from healthy subjects (30, 31) . ADHASCs can efficiently differentiate into mature adipocytes in vitro ( Supplementary Fig. 4 ). Differentiated mature adipocytes were treated with FFAs in the presence or absence of BMS-345541, the IKKb inhibitor. Consistently, BMS-345541 inhibited FFA-elicited NF-kB activation and IKKb-mediated BAD phosphorylation in human adipocytes (Fig. 8F) . Control human adipocytes were protected from FFA-induced cell death but BMS-345541-treated cells had elevated cleaved PARP and caspase-3 levels upon FFA treatment (Fig. 8F) . Taken together, these results demonstrated an essential role of IKKb in protecting both murine and human adipocytes from FFA-induced cell death.
DISCUSSION
In response to stresses linked to inflammation, cells are often forced to choose to die or survive. For example, in the immune system, TNF-a can signal both cell death and survival by activating JNK and IKKb signaling, respectively (36, 45) . Previous studies have demonstrated that activation of NF-kB promotes cell survival by inducing expression of genes encoding inhibitor of JNK signaling (36, 37) . In addition to NF-kB-dependent functions, IKKb can also inhibit TNF-a-induced apoptosis independently of NF-kB activation by phosphorylating and inactivating BAD, a key proapoptotic protein (38) . Similar to TNF-a, FFAs can activate both JNK and IKKb signaling in adipocytes (9, 10) . Although much attention has been focused on the role of IKKb in linking inflammation to insulin resistance, the function of IKKb in the regulation of adipocyte survival has not been thoroughly investigated. In the current study, we revealed an essential role of IKKb in promoting adipocyte survival in diet-induced obesity. Under standard laboratory conditions, deficiency of adipocyte IKKb did not affect adipose tissue development or metabolic function. However, when the mice were challenged with the HFD, IKKb and JNK signaling were both activated in control mice, and ablation of IKKb resulted in enhanced JNK activation and increased adipocyte death in IKKb
DAd mice. We also demonstrated that IKKb can phosphorylate BAD in adipocytes and that knockdown of BAD protected IKKb-deficient adipocytes from FFAinduced cell death, suggesting the importance of the IKKb-BAD axis in mediating adipocyte survival. IKKb is therefore a key adipocyte survival factor in obesity and can protect adipocytes from HFD-or FFA-elicited cell death through activation of the NF-kB-mediated survival factors and inactivation of the proapoptotic protein BAD (Fig. 8G) .
Several groups have previously studied the role of adipose IKKb/NF-kB signaling by overexpressing p65 or a constitutively active form of IKKb in adipose tissue (19, 20) . Surprisingly, these transgenic mice had increased adipose tissue inflammation but were resistant to dietinduced obesity and insulin resistance, which may be partially explained by the increased energy expenditure (19, 20) . However, we found that deletion of endogenous IKKb in adipocytes did not affect energy expenditure or diet-induced weight gain. While our work was in its final stages, Kwon et al. (21) also reported that deficiency of adipocyte IKKb led to visceral adipose tissue inflammation without affecting body weight or energy expenditure under HF conditions. It is plausible that endogenous IKKb in adipocytes does not affect energy metabolism at basal levels but that robustly constitutive activation of IKKb/NF-kB signaling may cause increased energy expenditure. Future studies are required to determine the detailed mechanisms through which IKKb/NF-kB signaling regulates energy homeostasis under basal and HF feeding conditions. Although the histopathologies in visWAT of our IKKb DAd mice were consistent with those Kwon et al. reported (21) , they attributed the increased inflammation phenotype to the decreased IL-13 expression of IKKb-deficient mice (21) . NF-kB signaling also plays an important role in inflammation resolution by regulating anti-inflammatory cytokines such as IL-10 and IL-13. However, IL-13 is one of many cytokines regulated by NF-kB signaling, and we found that the expression levels of both proinflammatory and anti-inflammatory cytokines, including MCP-1, TNF-a, IL-10, and IL-13, were all affected by IKKb deficiency in the epiWAT of HFD-fed mice. Further, both IL-10 and IL-13 gene expression was significantly increased rather than decreased in the epiWAT of IKKb DAd mice. Our mechanistic studies then suggest that the histopathologies in IKKb DAd mice are likely due to the loss of protection against cell death in response to HFD stress. Thus, adipose IKKb has other important functions beyond the scope of inflammation, and more studies are required to further investigate its role in obesity and insulin resistance.
The mechanisms triggering ATM recruitment remain incompletely understood (23, 46, 47) , and adipocyte death has been proposed as a key mechanism that leads to macrophage infiltration into adipose tissue and metabolic disorders (33) (34) (35) 39) . For example, Alkhouri et al. (39) demonstrated that adipocyte death was a link between obesity and insulin resistance. They also showed that genetic inactivation of a proapoptotic molecule can reduce adipocyte death, prevent ATM infiltration, and protect mice against insulin resistance. Consistent with their observations, we found that the increased adipocyte death in visWAT of IKKb DAd mice was associated with massive macrophage infiltration and elevated levels of proinflammatory cytokines. Increased ATM number has also been associated with elevated adipose lipolysis and circulating FFA levels (40) . Indeed, deficiency of IKKb increased adipose lipolysis and plasma FFA levels, leading to ectopic hepatic lipid accumulation and impaired insulin signaling.
That ATM accumulation in IKKb
DAd mice is driven by increased lipolysis is also possible, and whether IKKb can directly regulate adipocyte lipolysis would be an interesting study in the future.
It is intriguing that deficiency of adipocyte IKKb promoted HFD-induced adipocyte death and ATM infiltration in visceral but not in subcutaneous fat. The regional differences between different fat depots have been well-recognized (48) and there is a major ontogenetic difference between visceral and subcutaneous fat because they have different developmental origins (49) . HF feeding also rapidly and specifically activates adipogenesis in visceral but not in subcutaneous adipose tissue in mice (50) . Consistently, adipocyte death rate was much higher in visWAT after long-term HF feeding (34) . It is plausible that visceral adipocytes are more susceptible to HFD-induced cell death and that ablation of IKKb therefore has detectable deleterious effects on visceral adipocytes compared with subcutaneous adipocytes. Future studies will be required to determine the detailed mechanisms that account for the different effects of IKKb ablation on visceral versus subcutaneous fat.
In summary, we have revealed a pivotal role of IKKb in adipocyte survival and adipose remodeling in obesity. IKKb promotes adipocyte survival through NF-kBdependent and NF-kB-independent mechanisms. Deficiency of IKKb in adipocytes causes defects in adaptive adipose remodeling in response to dietary change, leading to an exaggerated diabetic phenotype coupled to partial lipodystrophy in visceral adipose tissue. IKKb is therefore a key adipocyte survival factor and is required for adaptive adipose remodeling in obesity.
